Cell Impact reports fourth quarter results: Solid year-end results 2022
Cell Impact AB (Nasdaq First North GM: CI) reports the following summary for the fourth quarter.The higher production activity trend Cell Impact saw at the end of the third quarter also continued into the fourth quarter. During the quarter, we received a number of small, but important, orders for test tools that we expect will become full-scale tooling projects and prototype series during 2023. In industrial terms, Cell Impact continued to develop through further enhancing production equipment and strong growth in flow plate production. Even if new orders for important tooling projects